Oseltamivir

🧮 Dose calculator

Influenza (flu) · Regimen source: FDA Oseltamivir susp · 2.2, Table 1

• • Start within 48 hours of symptom onset; 5 days. Better tolerated with food. FDA Oseltamivir susp · 2.2FDA Oseltamivir susp · 2.1

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Oseltamivir susp · 8.1

  “Risk Summary There are no adequate and well-controlled studies with oseltamivir phosphate for oral suspension in pregnant women to inform a drug‐associated risk of adverse developmental outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Oseltamivir susp · 8.2

  “Risk Summary Based on limited published data, oseltamivir and oseltamivir carboxylate have been shown to be present in human milk at low levels considered unlikely to lead to toxicity in the breastfed infant.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Oseltamivir susp · 8.4

  “Treatment of Influenza The safety and efficacy of oseltamivir phosphate for the treatment of influenza in pediatric patients 2 weeks old to 17 years of age has been established [see Dosage and Administration ( 2.2 ), Clinical Pharmacology (12.3), and Clinical Studies ( 14.1 )] and is based on: 13 to 17 years of age: …”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Oseltamivir susp · 8.5

  “… tients at least 65 years old, that enrolled 741 subjects (374 received placebo and 362 received oseltamivir phosphate), no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses …”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.